Eisai
4523.T
23,68 €
Share price
2.60%
Change (1 day)
-35.84%
Change (1 year)
Categories
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.
Earnings for Eisai (4523.T)
Earnings in 2024 (TTM): €0.40 Billion
According to Eisai's latest financial reports the company's current earnings are €5.06 Billion. In 2023 the company made an earning of €0.46 Billion, an increase over its 2022 earnings that were of -€20.25 Million. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Eisai from 2009 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024 (TTM)  | €0.40 B | -13.04% |
| 2023 | €0.46 B | -2392.87% |
| 2022 | -€20.25 Million | -103.6% |
| 2021 | €0.56 B | -39.52% |
| 2020 | €0.93 B | 7.3% |
| 2019 | €0.86 B | 17.23% |
| 2018 | €0.73 B | 86.06% |
| 2017 | €0.39 B | -23.64% |
| 2016 | €0.52 B | 27.28% |
| 2015 | €0.40 B | 22.08% |
| 2014 | €0.33 B | -46.11% |
| 2013 | €0.62 B | -21.67% |
| 2012 | €0.79 B | -20.72% |
| 2011 | €1.00 B | -8.44% |
| 2010 | €1.09 B | 18.85% |
| 2009 | €0.91 B |